Pfizer : PFE

All Pfizer Articles

1482 Articles

Trey Thoelcke | Apr 12, 2016 at 6:50 AM EDT

The 5 Most Shorted NYSE Stocks: Big Changes to End the Quarter

Some moves in the most heavily shorted stocks traded on the New York Stock Exchange were sizable between the March…

Trey Thoelcke | Apr 7, 2016 at 9:10 AM EDT

Why the Pfizer-Allergan Breakup Could Be Bad News for Apple and Alphabet

The breakup of the Pfizer-Allergan deal may only be a warning sign for both Apple and Google and any other…

Lee Jackson | Apr 7, 2016 at 8:55 AM EDT

Top Analysts Upgrade and Downgrades: Apple, Coach, EMC, Hewlett Packard Enterprise, Pfizer, Verizon and More

Thursday's top analyst upgrades, downgrades and initiations include Apple, Coach, EMC, Hewlett Packard Enterprise, Pfizer and Verizon.

Paul Ausick | Apr 6, 2016 at 4:01 PM EDT

The 4 Stocks That Dominated the Dow on Wednesday

April 6, 2016: Markets opened higher on Wednesday following mixed trading in Asia. The dollar weakened and the release of…

Douglas A. McIntyre | Apr 5, 2016 at 5:17 PM EDT

Big Company Executives Attack Government on Inversion Stance

The Business Roundtable, the primary representatives of the CEOs of America's largest companies, made a statement about business combinations that…

Chris Lange | Apr 3, 2016 at 10:10 AM EDT

The 6 Dow Stocks Holding the Market Down in 2016

After much waiting, the broad markets and the Dow Jones Industrial Average in particular have made it back to positive…

Paul Ausick | Apr 1, 2016 at 4:01 PM EDT

The 4 Stocks That Lifted the DJIA on Friday

ThinkstockApril 1, 2016: Markets opened lower on Friday following the monthly employment report from the Bureau of Labor Statistics. The…

Paul Ausick | Mar 31, 2016 at 4:01 PM EDT

The 4 Stocks That Weighed Down the DJIA on Thursday

March 31, 2016: Markets opened higher again on Thursday but only the Nasdaq Composite was able to hold on for…

Lee Jackson | Mar 30, 2016 at 11:05 AM EDT

Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts

Long-term growth investors looking for a degree of safety and value should consider some of these outstanding companies. While the…

Trey Thoelcke | Mar 25, 2016 at 6:20 AM EDT

The 5 Most Shorted NYSE Stocks: Pfizer Surges to the Top

Interest in almost all of the most heavily shorted stocks traded on the New York Stock Exchange shrank between the…

Paul Ausick | Mar 21, 2016 at 4:01 PM EDT

The 4 Stocks That Buoyed the Dow on Monday

March 21, 2016: Markets opened lower on Monday on some weakness overnight in oil prices. The morning report on existing…

Chris Lange | Mar 18, 2016 at 12:40 PM EDT

Pfizer Posts Positive Late-Stage Results in Colitis Trials

Pfizer announced the results from its first two pivotal Phase 3 studies from the Oral Clinical Trials for tofacitinib in…

Lee Jackson | Mar 18, 2016 at 8:25 AM EDT

4 Merrill Lynch US 1 Dividend Stocks to Buy for Continued Low Rates

So what are investors to do in a continued low rate environment? Buy the best stocks out there, especially ones…

Chris Lange | Mar 15, 2016 at 10:20 AM EDT

Huge Opportunity, and Risks, in 5 Top Abuse-Deterrent ER Opioids

One analyst firm believes the development of abuse-deterrent formulations (ADF) of opioids creates a risk that older non-ADFs may be…

Chris Lange | Mar 15, 2016 at 9:25 AM EDT

Jefferies Top Drug Stocks for the Rest of 2016

For the most part, Jefferies maintained its list of top companies in the health care sector, but it also made…

1 … 50 51 52 53 54 … 99

Pfizer : PFE

All Pfizer Articles

The 5 Most Shorted NYSE Stocks: Big Changes to End the Quarter

Why the Pfizer-Allergan Breakup Could Be Bad News for Apple and Alphabet

Top Analysts Upgrade and Downgrades: Apple, Coach, EMC, Hewlett Packard Enterprise, Pfizer, Verizon and More

The 4 Stocks That Dominated the Dow on Wednesday

Big Company Executives Attack Government on Inversion Stance

The 6 Dow Stocks Holding the Market Down in 2016

The 4 Stocks That Lifted the DJIA on Friday

The 4 Stocks That Weighed Down the DJIA on Thursday

Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts

The 5 Most Shorted NYSE Stocks: Pfizer Surges to the Top

The 4 Stocks That Buoyed the Dow on Monday

Pfizer Posts Positive Late-Stage Results in Colitis Trials

4 Merrill Lynch US 1 Dividend Stocks to Buy for Continued Low Rates

Huge Opportunity, and Risks, in 5 Top Abuse-Deterrent ER Opioids

Jefferies Top Drug Stocks for the Rest of 2016

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Nvidia’s CEO Sees Marvell Becoming the Next $1 Trillion Company. Shares Gained Another 5% Today.

Middle-Class Fortysomethings Have a $427,000 Problem and a Shrinking Window to Fix It

The $43,000-a-Year 401(k) Withdrawal That Keeps a $1.4 Million Retiree in the 12% Bracket for Life

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Pfizer : PFE

All Pfizer Articles

The 5 Most Shorted NYSE Stocks: Big Changes to End the Quarter

Why the Pfizer-Allergan Breakup Could Be Bad News for Apple and Alphabet

Top Analysts Upgrade and Downgrades: Apple, Coach, EMC, Hewlett Packard Enterprise, Pfizer, Verizon and More

The 4 Stocks That Dominated the Dow on Wednesday

Big Company Executives Attack Government on Inversion Stance

The 6 Dow Stocks Holding the Market Down in 2016

The 4 Stocks That Lifted the DJIA on Friday

The 4 Stocks That Weighed Down the DJIA on Thursday

Top Dividend-Paying Pharmaceutical Stocks Rated Buy by Analysts

The 5 Most Shorted NYSE Stocks: Pfizer Surges to the Top

The 4 Stocks That Buoyed the Dow on Monday

Pfizer Posts Positive Late-Stage Results in Colitis Trials

4 Merrill Lynch US 1 Dividend Stocks to Buy for Continued Low Rates

Huge Opportunity, and Risks, in 5 Top Abuse-Deterrent ER Opioids

Jefferies Top Drug Stocks for the Rest of 2016

Crypto Crash Today: Why Bitcoin, Ethereum, XRP, and Solana Are All Down Double Digits

Billionaire Bill Ackman’s Pershing Square Exits Universal Music After Failed Takeover Bids, Stock Slumps 7%

Nvidia’s CEO Sees Marvell Becoming the Next $1 Trillion Company. Shares Gained Another 5% Today.

Featured Reads

Middle-Class Fortysomethings Have a $427,000 Problem and a Shrinking Window to Fix It

The $43,000-a-Year 401(k) Withdrawal That Keeps a $1.4 Million Retiree in the 12% Bracket for Life